Analysts see recovery potential in Intuitive Surgical and Novo Nordisk amid growth worries
Stock picks across a mix of growth and large-cap names show a balance of long-term upside and near-term headwinds: Intuitive Surgical and Novo Nordisk are presented as attractive long-term buys despite recent challenges, while TXN and ODFL face slowing growth and margin pressure, warranting caution on valuation. Additional lists flag mixed signals for Teradata and RUM Group, Allegro MicroSystems and First Watch as high- or mid-duration risks, Twilio and ADM as examples of growth or margin struggles in large-cap names, underscoring the broader theme of weighing quality against price in today’s market.
Business · 6 sources · Sep 4, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About Intuitive Surgical
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Everything about Intuitive Surgical →- Country
- United States
- Headquarters
- Sunnyvale
- Inception
- 1995
- Website
- https://www.intuitive.com